CARDIOVASCULAR DISEASES

Biomarkers for Cardiovascular Disease

Main lines of research

  • Identification of new biomarkers of atherothrombosis and ischaemic heart disease with potential use in diagnosis and prognosis research is based on cell culture studies, animal models of cardiovascular disease and human samples of patients with coronary heart disease risk factors.

Challenges

  • Advance research aiming to identify and characterize new biomarkers of vascular injury, atherothrombotic disease and/or ischaemic, coronary and cerebrovascular syndromes using postgenomic techniques.
  • Generate new information on potential soluble biomarkers (in serum, plasma) and in microparticles circulating in blood, as well as in blood and/or vascular cells studies include proteomic and lipidomic techniques based on liquid chromatography and bidimensional electrophoresis, antibody array systems and mass spectrometry (MALDIToF/ToF; linear ion trap).
  • Validate biomarkers identified in the diagnosis and prognosis of cardiovascular and/or cerebrovascular disease using specific quantitative techniques (confocal microscope, ELISA, multiplex assays, etc).
  • Characterize molecular and functional mechanisms for selected biomarkers in cardiovascular pathology (biology of systems).
  • Consolidate the lipidomic platform.
  • Lead the Biobank in the SAFE-T European project.

This website uses cookies to improve the browsing experience and perform analytical tasks. If you continue browsing, we understand that you agree our cookies policy. More information